Frédéric Féru
Impact in
-
- Peptidase Inhibition and Analysis
-
- Protein Degradation and Inhibitors
- Ubiquitin and proteasome pathways
- Protein Kinase Regulation and GTPase Signaling
- Melanoma and MAPK Pathways
- Cancer therapeutics and mechanisms
Papers in
-
- Melanoma and MAPK Pathways 3
- Protein Degradation and Inhibitors 1
- Oncology 3
- Peptidase Inhibition and Analysis 2
- Cancer Treatment and Pharmacology 1
- Co-authors
- Thomas W. Gero (5 shared papers)David A. Scott (5 shared papers)Nathanael S. Gray (5 shared papers)Pasi A. Jänne (3 shared papers)Yuan Xiong (2 shared papers)Eric S. Fischer (2 shared papers)Kenneth D. Westover (2 shared papers)Chunshan Quan (2 shared papers)
- Journals
- Bioorganic & Medicinal Chemistry Letters (5 papers)Cell chemical biology (2 papers)Chemical Biology & Drug Design (1 paper)
- Partner nations
- United StatesSouth AfricaFrance
In The Last Decade
Frédéric Féru
8 papers receiving 443 citations
Peers
Comparison fields: 5 of 44
- Oncology 172
- Molecular Biology 396
- Hematology 59
- Cell Biology 60
- Organic Chemistry 56
Countries citing papers authored by Frédéric Féru
This map shows the geographic impact of Frédéric Féru's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frédéric Féru with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frédéric Féru more than expected).
Fields of papers citing papers by Frédéric Féru
This network shows the impact of papers produced by Frédéric Féru. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frédéric Féru. The network helps show where Frédéric Féru may publish in the future.
Co-authors
The 25 scholars most cited alongside Frédéric Féru, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 207 | |
| 2 | 2017 | 101 | |
| 3 | 2007 | 95 | |
| 4 | 2000 | 16 | |
| 5 | 2022 | 13 | |
| 6 | 2010 | 9 | |
| 7 | 2020 | 8 | |
| 8 | 2020 | 4 |
About Frédéric Féru
Frédéric Féru is a scholar working on Molecular Biology, Oncology, Cell Biology, Organic Chemistry and Cellular and Molecular Neuroscience, having authored 8 papers that have together received 453 indexed citations. Recurring topics across this work include Melanoma and MAPK Pathways (3 papers), Microtubule and mitosis dynamics (2 papers), Neuroscience and Neuropharmacology Research (2 papers), Peptidase Inhibition and Analysis (2 papers), Cholinesterase and Neurodegenerative Diseases (1 paper), Protein Degradation and Inhibitors (1 paper), Quinazolinone synthesis and applications (1 paper) and Cancer Treatment and Pharmacology (1 paper). The work is most often cited by research in Oncology (172 citations), Molecular Biology (396 citations), Hematology (59 citations), Cell Biology (60 citations) and Organic Chemistry (56 citations). Frédéric Féru has collaborated with scholars based in United States, South Africa and France. Frequent co-authors include Thomas W. Gero, David A. Scott, Nathanael S. Gray, Pasi A. Jänne, Yuan Xiong, Eric S. Fischer, Kenneth D. Westover, Chunshan Quan, Lianbo Li and Cyrille Kuhn. Their work appears in journals such as Bioorganic & Medicinal Chemistry Letters, Cell chemical biology and Chemical Biology & Drug Design.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.